Evidence map›Paper›PMID 38630893›Full record

ArticleCancer research communications2024

Small Extracellular Vesicles Promote Stiffness-mediated Metastasis.

Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R Nair, Carolyn Marar, Najwa Faqih, Gabrielle E Ciotti, Joo Ho Kim, Sejal Krishnan and 14 more

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Caveolae mechanics in cellular functions and disease.Nature reviews. Molecular cell biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.International journal of molecular sciences · 2025
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 2 countries.

Alexandra Sneider *Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-8575-3084
Ying Liu *Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0009-0004-8992-357X
Bartholomew Starich *Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-0006-0236
Wenxuan DuDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0003-4117-0623
Praful R NairDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-5875-4743
Carolyn MararJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-9636-8368
Najwa FaqihJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0009-0001-7941-5342
Gabrielle E CiottiAbramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0009-0002-3789-0919
Joo Ho KimDepartment of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0003-2904-8780
Sejal KrishnanJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0009-0007-1561-2228
Salma IbrahimJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0009-0005-4639-592X
Muna IgbokoJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-6738-5983
Alexus LockeJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0003-4475-101X
Daniel M LewisDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-9147-3038
Hanna HongJohns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-6637-8573
Michelle N KarlDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0003-3306-701X
Raghav VijW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0001-5812-0484
Gabriella C RussoDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-4492-2571
Estibaliz Gómez-de-MariscalBioengineering and Aerospace Engineering Department, Universidad Carlos III de Madrid, Leganés, Spain.ORCID 0000-0003-2082-3277
Mehran HabibiJohns Hopkins Breast Center, Johns Hopkins Bayview Medical Center, Baltimore, Maryland.ORCID 0000-0003-2944-4388
Arrate Muñoz-BarrutiaBioengineering and Aerospace Engineering Department, Universidad Carlos III de Madrid, Leganés, Spain.ORCID 0000-0002-1573-1661
Luo GuDepartment of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-9813-7202
T S Karin Eisinger-MathasonAbramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0003-4959-3671
Denis WirtzDepartment of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-6147-3045
Johns Hopkins University · USUniversity of Pennsylvania · USHospital General Universitario Gregorio Marañón · ES

Funding

TRANS NETWORK PROJECTSU54CA143868 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2009 to 2013
$13.7M
Tech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz, Laura DeLong Wood · 2022 to 2026
$10.2M
The Role of Physical Cues in Collective Cell InvasionU54CA210173 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2016 to 2020
$9.9M
Single-cell phenotyping for therapeutic stratification in pancreatic cancerR01CA174388 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2012 to 2016
$3.8M
Validation of Nuclear Morphology as a Biomarker of Aging and Aging-Related PhenotypesU01AG060903 · NIA · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2018 to 2022
$3.1M
Organ Specific ProjectU54AR081774 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI REDDY, SASHANK K, WIRTZ, DENIS · 2022 to 2023
$1.1M
NCI NIH HHS R01 CA174388NCI NIH HHS U54 CA143868NCI NIH HHS U54 CA210173NCI NIH HHS U54 CA268083NIAMS NIH HHS U54 AR081774NIA NIH HHS U01 AG060903
6 · The paper itself

Abstract

Tissue stiffness is a critical prognostic factor in breast cancer and is associated with metastatic progression. Here we show an alternative and complementary hypothesis of tumor progression whereby physiologic matrix stiffness affects the quantity and protein cargo of small extracellular vesicles (EV) produced by cancer cells, which in turn aid cancer cell dissemination. Primary patient breast tissue released by cancer cells on matrices that model human breast tumors (25 kPa; stiff EVs) feature increased adhesion molecule presentation (ITGα2β1, ITGα6β4, ITGα6β1, CD44) compared with EVs from softer normal tissue (0.5 kPa; soft EVs), which facilitates their binding to extracellular matrix proteins including collagen IV, and a 3-fold increase in homing ability to distant organs in mice. In a zebrafish xenograft model, stiff EVs aid cancer cell dissemination. Moreover, normal, resident lung fibroblasts treated with stiff and soft EVs change their gene expression profiles to adopt a cancer-associated fibroblast phenotype. These findings show that EV quantity, cargo, and function depend heavily on the mechanical properties of the extracellular microenvironment. SIGNIFICANCE: Here we show that the quantity, cargo, and function of breast cancer-derived EVs vary with mechanical properties of the extracellular microenvironment.

Indexed as

Breast NeoplasmsExtracellular VesiclesTumor MicroenvironmentZebrafishAnimalsCell Line, TumorExtracellular MatrixFemaleHumansMiceNeoplasm Metastasis

Identifiers

PMID38630893
PMCPMC11080964
OpenAlexW4394872314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.